missing translation for 'onlineSavingsMsg'
Learn More

Chitinase 3-like 2 Antibody (1B2.G4), Novus Biologicals™

Mouse Monoclonal Antibody

256.00 € - 484.00 €

Specifications

Antigen Chitinase 3-like 2
Clone 1B2.G4
Concentration 0.2 mg/ml
Applications ELISA, Functional Assay
Classification Monoclonal
View More Specs

Products 2
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
30302898
View Documents
Novus Biologicals
NBP3-44589-20ug
20 μg
256.00 €
20µg
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
30294631
View Documents
Novus Biologicals
NBP3-44589-100ug
100 μg
484.00 €
100µg
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
Description

Description

Chitinase 3-like 2 Monoclonal antibody specifically detects Chitinase 3-like 2 in Human samples. It is validated for ELISA,Functional Assay
Specifications

Specifications

Chitinase 3-like 2
0.2 mg/ml
Monoclonal
Purified
RUO
Human
chitinase 3-like 2, chitinase-3-like protein 2, Chondrocyte protein 39, YKL-39YKL39
Recombinant human fragment corresponding to Chitinase 3-like 2 protein (Uniprot: Q15782). Exact sequence is proprietary.
Primary
Store at 4⪚C.
1B2.G4
ELISA, Functional Assay
Unconjugated
Mouse
Stem Cells
10 mM PBS with 0.05% BSA
1117
IgG2 κ
Protein A purified
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.